Patrick Metke
Defilade Capital Management, L.p.
Assets Managed
$712.176M
Holdings
31
Last Quarter
2026 - Q1
Filed Date
3d ago
Growth Rate
-3.46%(2Q avg: -1.73%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Defilade Capital Management, L.p.'s 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 31 positions.
Assets under management
The assets under management (AUM) of Defilade Capital Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 712.176M in assets, with a quarterly growth rate of -3.46% and a 2-quarter average growth rate of -1.73%. The portfolio is managed by Patrick Metke, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
ZBH Zimmer Biomet Holdings Inc
| 7.36% | $52.368M 579,161 shares@ $90.43 avg price | New Position |
HSIC Henry Schein Inc
| 6.46% | $45.992M 624,037 shares@ $73.71 avg price | Increased 94.76% |
BDX Becton Dickinson And Co
| 6.17% | $43.9M 279,210 shares@ $157.23 avg price | Increased 243.83% |
PTCT Ptc Therapeutics Inc
| 5.78% | $41.113M 376,165 shares@ $109.3 avg price | New Position |
DXCM Dexcom Inc
| 4.76% | $33.834M 538,762 shares@ $62.81 avg price | Increased 120.01% |
ICUI Icu Medical Inc
| 4.62% | $32.842M 254,291 shares@ $129.16 avg price | Decreased -25.37% |
INSM Insmed Inc
| 4.48% | $31.872M 194,909 shares@ $163.53 avg price | Increased 289.82% |
ISRG Intuitive Surgical Inc
| 4.39% | $31.2M 67,681 shares@ $460.99 avg price | Increased 48.23% |
RVMD Revolution Medicines Inc
| 4.32% | $30.728M 315,972 shares@ $97.25 avg price | Decreased -13.06% |
GMED Globus Medical Inc - A
| 4.29% | $30.531M 354,350 shares@ $86.16 avg price | Increased 32.62% |
1-10 of 31